The Reality is......20 Apr 2020 22:06
All credit to poster 'lithological heterogeneities' from the other site, below puts everything into context and screams out why you want to be holding on to whatever shares you have for massive future gains that this company should return this year and beyond!
"DnaNudge Lab-in-Cartridge test:
•DnaNudge Results in 1 hour. No lab.
•DnaNudge still needs "large-scale clinical testing with a view to extensive national roll-out" so not ready for quite some time yet.
•DnaNudge has no worldwide multi-billion dollar partners to manufacture/distribute worldwide. immediately.
•DnaNudge is a private company.
-----------------------------------------------------------------------
AVCT test:
•AVCT results in 10 mins.No lab.
•AVCT test already PROVEN against Zika virus.
•AVCT successful completion of Affimer expected within 2 weeks.
•AVCT immediate Worldwide manufacture and distribution of the on-the-spot saliva test via partner $21.5 billion Cytiva,owned by $96 billion Danaher.
•AVCT test will also be used seperate to Cytiva agreement for government mass process testing via a lab.
•Investors cannot make money on DnaNudge so investors have no reason to sell AVCT to buy shares in this company as they are not listed. Indeed,DnaNudge announced this new Covid-19 test on 10 April and has had zero impact on AVCT share price.
-----------------------------------------------------------------------
In short - NO COMPETITION as they say ""large-scale clinical testing with a view to extensive national roll-out"
There will be BILLIONS of tests and BILLIONS OF RE-TESTS required worldwide. The market is absolutely massive and multiple companies can make absolute fortunes side by side with each other.
In my opinion,AVCT is STILL by far the best,quickest,and ready to begin mass production on a worldwide scale via $21.5 billion/$96 billion partners Cytiva/Danaher.
This is going to be HUGE Worldwide news and will signal the return to work of billions of people worldwide and save economies BILLIONS and BILLIONS of pounds.
I still expect £5-£10 per share on successful Covid-19 affimer completion and announcement of IMMEDIATE Worldwide manufacture and distribution."
Sign In
Follow the stocks
